Searched for
SUN PHARMA TARO
Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...- Sun's strong gravity helps India Inc's pullSun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma completes merger of TaroAs part of this merger, Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its...
- Taro shareholders approve merger with Sun PharmaThe combined entity will enable the company to better serve the needs of patients, healthcare professionals and customers around the world,...
- Sun Pharma to buy remaining 21.5% in Taro for Rs 2,892 crSun Pharma, India's largest drugmaker, is set to acquire the remaining 21.52% stake in Israel-based Taro Pharmaceutical Industries for ₹2,8...
- Sun Pharma raises offer to buy Taro Pharmaceutical Industries' US armOn May 26, 2023, Sun Pharmaceutical proposed via a letter to Taro's Board of Directors a non-binding indication of interest to acquire all ...
- Taro appoints Mariano Balaguer its new CFOTaro said Balaguer comes with 20 years of experience in finance with global companies such a Novartis Consumer Health, Nestle and Henry Sch...
- Sun Pharma drops plan to buy out Taro’s minority shareholdersSun Pharma had acquired majority stake (66%) in the Israeli generic firm Taro Pharma in 2007 for $450 million, but got control of the compa...
- Sun Pharma under scanner for under-reporting Taro's Q3 resultsA minority shareholder of Taro Pharma has alleged that the company's financial results have been under-reported by its Indian promoter, Sun...
- Taro Pharma panel turns down Sun Pharma's open offer priceSun Pharma, which holds about 67% stake in Taro, had made an open offer of $24.50 a share last year for the remaining stake.
- Guardian Point asks Sun Pharma to up Taro Pharma offerGuardian Point Capital, one of the minority shareholders of Israeli firm Taro Pharma, has asked Sun Pharma to revise $24.50 share price off...
- Sun Pharma says won't revise taro offer priceMumbai-based Sun Pharma will not revise its offer price to minority shareholders of Isreali drug maker Taro pharma, a company official said.
- Taro integration worries weigh on Sun Pharma investorsThe latest verdict of the Israeli Supreme Court will enable Sun Pharma to increase its stake in Taro to around 53 per cent.
- Taro drags Sun to court againSun Pharmaceuticals has been slapped with another lawsuit. The Mumbai-based pharma company has been sued by Taro Pharmaceuticals, the Israe...
- Sun, Taro get extra time to resolve disputeThe Israeli Supreme Court has given Sun Pharma and Taro Pharmaceuticals a month to reach an out-of-court settlement.
- Taro's share fall lights up buyout hopes for SunThe Indian pharma firm’s open offer to Taro shareholders is on and Taro is currently trading $7.75 below the price offered by Sun Pharma. T...
- Sun Pharma’s Taro bid faces new hurdleTaro shareholder Templeton Asset rejects offer, says it does not reflect correct value.
- Sun tightens grip on Taro, ups stakeSun Pharmaceuticals has consolidated its position in Taro Pharma, the Israeli company it agreed to buy for about $454 million in June, even...
Load More
